Cell-mediated Immune Responses
Myocarditis I: Introduction
T Cell Activation and Clonal Selection
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Cells of the Adaptive Immune Response
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 20, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Silvia Fanti1, Edward Stephenson1,2, Etel Rocha-Vieira1,3
1William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry (S.F., E. Stephenson, E.R.-V., S.K., E. Shahaj, M.P.L., V.S.V., C.D., E.P., M.B., D.C., G.W., D.H., E. Solito, K.S., S.A.M., F.M.M.-B.), Queen Mary University of London, UK.
Circulating c-mesenchymal epithelial transition factor (c-Met)-positive T cells are elevated in inflammatory heart muscle diseases. Targeting these cells may offer new therapeutic strategies for cardiac autoimmunity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: